The salbutamol oral liquid market size has grown robustly in recent years, growing from $1.11 billion in 2024 to $1.17 billion in 2025, indicating a compound annual growth rate CAGR of 5.7%.

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

Salbutamol and terbutaline are similar β-2 adrenoceptor agonists that are believed to exert their maximal therapeutic effect through bronchodilation. Stimulation of β-2 receptors in airway smooth ...

Treatment with salanersen slowed neurodegeneration and improved motor function in children with SMA in a Phase 1 trial, interim results show.